1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
Follow Hua Li: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies lenvatinib + anti-PD-1 antibodies, ablation - Hepatocellular Carcinoma | Phase 1 | Unknown | Hua Li | 70 | 2024-01-01 | 2024-07-24 |
lenvatinib (1)
China (1)